Delivery Order SPE2DB22D3011-SPE2DB25FP8NR

Award Date 1/13/25
Potential Completion Date 2/4/25
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $12,960.30, is for the delivery of Vyndamax 61 mg capsules. The contract is a firm fixed price delivery order, with a period of performance ending on November 29, 2024. The award was made on November 6, 2024. The contract does not have a set-aside designation, indicating it was open to full and open competition. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,920.62 Firm Fixed Price Delivery Order is for the drug VYNDAMAX 61 MG CAPSULE UD 30S, with a period of performance through November 7, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with an award value of $13,408.24, is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a specialty pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of December 16, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $25,920.62 contract is for the supply of Vyndamax 61 mg capsules, a medication used in the treatment of heart disease. The award has an ultimate completion date of November 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,408.24 firm fixed-price contract is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, with a performance period ending on January 17, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Vyndamax 61 mg capsules. The contract has a firm fixed price of $25,920.62 and is scheduled for completion by September 12, 2024. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,960.30 firm fixed-price delivery order is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a specialty medication. The contract has an ultimate completion date of November 27, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This federal contract award, valued at $12,960.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is a delivery order for the pharmaceutical product VYNDAMAX 61 MG CAPSULE UD 30S, with a performance period through September 30, 2024. The contract type is firm fixed price. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, under which AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,408.24 Firm Fixed Price delivery order is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a specialty pharmaceutical product. This award is associated with an Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $40,224.72, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, with a period of performance through January 29, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB25FP8NR
    Delivery Order

This federal contract award, with ID SPE2DB22D3011|SPE2DB25FP8NR, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,408.24 firm fixed-price delivery order is for the supply of Vyndamax 61 mg capsules, a medication used in the treatment of a specific medical condition. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 4/14/25, 10:44 AM